Publicações – BiobadaBrasil

Publicações Integrais

• The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis. Bredemeier M, Duarte ÂL, Pinheiro MM, Kahlow BS, Macieira JC, Ranza R, Miranda JR, Valim V, de Castro GR, Bértolo MB, Sauma MF, Fernandes V, Ribeiro AC, Teodoro RB, Brenol CV, Carvalho HM, Studart SA, Pinheiro GR, da Rocha LF Jr, de Lima HD, Pereira IA, Gazzeta MO, Kakehasi AM, Louzada P Jr, Hayata AL, Lupo CM, da Silveira IG, Kowalski SC, Titton DC, Chakr RM, Ranzolin A, Xavier RM, Laurindo IM. Rheumatology (Oxford). 2024 Feb 1;63(2):456-465. doi: 10.1093/ rheumatology/kead232.PMID: 37216912
• Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever. Ranzolin A, Marques CDL, da Rocha Junior LF, Duarte ALBP, de Lima HD, de Almeida Martins LM, de Almeida AR, de Oliveira PSS, de Melo Rêgo MJB, da Rocha Pitta MG, Bredemeier M, Laurindo IMM. Adv Rheumatol. 2022 Nov 14;62(1):44. doi: 10.1186/s42358-022-00273-0.PMID: 36376923
• Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil) .Bredemeier M, Ranza R, Kakehasi AM, Ranzolin A, da Silveira IG, Ribeiro ACM, Titton DC, Hayata ALS, Carvalho HMS, Kahlow BS, Fernandes V, Louzada P Jr, Bértolo MB, Duarte ÂLBP, Macieira JC, Miranda JRS, Pinheiro GRC, Teodoro RB, Pinheiro MM, Valim V, Pereira IA, Sauma MFLC, de Castro GRW, da Rocha LF Jr, Studart SAS, Gazzeta MO, da Silveira LG, Lupo CM, Laurindo IMM.J Rheumatol. 2022 Jan;49(1):122. doi: 10.3899/jrheum.201248.C1.
• Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring. Cecconi M, Ranza R, Titton DC, Moraes JCB, Bertolo M, Bianchi W, Brenol C, Carvalho HM, de Castro GRW, Costa IP, Cunha MFL, Duarte Â, Fernandes V, Freire M, Louzada-Junior P, Macieira JC, Miranda JRS, Pereira IA, Pinheiro GRC, Stadler B, Toledo RA, Valim V, Descalzo MA, Pinto RMC, Laurindo I. J Clin Rheumatol. 2020 Mar;26(2):73-78. doi: 10.1097/RHU.0000000000000935. PMID: 32073519
• Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR. Ranza R, de la Vega MC, Laurindo IMM, Gómez MG, Titton DC, Kakehasi AM, Brigante A, Benitez A, Ranzolin A, Granel A, Cappuccio AM, Quinteros A, Hayata ALS, Smichowski A, Duarte ÂLBP, Kahlow BS, Andia CS, Brenol CV, Velozo E, Mussano E, Soriano ER, Christopoulos GB, da Rocha Castelar Pinheiro G, de Castro GRW, Casado G, da Silveira Carvalho HM, Exeni IE, da Silveira IG, Petkovic I, Pereira IA, da Costa IP, Rosa JE, Miranda JRS, de Moraes JCB, Bertolo MB, Buhl M, Lázaro MA, da Sauma MFLC, de Medeiros Pinheiro M, Díaz M, de Vechi MVSS, Cerda OL, Astesana P, Curi PF, Louzada-Jr P, Teodoro RB, Toledo RA, Papasidero S, Valim V, Fernandes V, Saurit V, Bianchi WA; BIOBADABRASIL study group, Sociedade Brasileira de Reumatologia and of the BIOBADASAR study group, Sociedad Argentina de Reumatologia; de Melo Costa Pinto R, Descalzo MA, Gomez-Reino JJ. Clin Rheumatol. 2019 Aug;38(8):2129-2139. doi: 10.1007/s10067-019-04516-2. Epub 2019 Apr 17.PMID: 31016578
• Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitoração de Terapias Biológicas – BiobadaBrasil).Yonekura CL, Oliveira RDR, Titton DC, Ranza R, Ranzolin A, Hayata AL, Duarte Â, Silveira IG, Carvalho HMDS, Moraes JCB, Abreu MM, Valim V, Bianchi W, Brenol CV, Pereira IA, Costa I, Macieira JC, Miranda JRS, Guedes-Barbosa LS, Bertolo MB, Sauma MFLDC, Silva MBG, Freire M, Scheinberg MA, Toledo RA, Oliveira SKF, Fernandes V, Pinheiro MM, Castro G, Vieira WP, Baaklini CE, Ruffino-Netto A, Pinheiro GDRC, Laurindo IMM, Louzada-Junior P.Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:477-483. doi: 10.1016/j.rbre.2017.05.005.
• Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.Fafá BP, Louzada-Junior P, Titton DC, Zandonade E, Ranza R, Laurindo I, Peçanha P, Ranzolin A, Hayata AL, Duarte A, Silveira IG, Costa I, Macieira JC, Guedes-Barbosa LS, Bertolo MB, Sauma MF, Silva MB, Freire M, Scheinberg MA, Fernandes V, Bianchi W, Miranda JR, Pinheiro GR, Carvalho HM, Brenol CV, Pereira IA, de Castro GR, de Morais JC, Oliveira SK, de Abreu MM, Toledo RA, Pinheiro MM, Vieira WP, Valim V; BIOBADABRASIL. Clin Rheumatol. 2015 May;34(5):921-7. doi: 10.1007/s10067-015-2929-7.
• BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries. Carmona L, de la Vega M, Ranza R, Casado G, Titton DC, Descalzo MÁ, Gómez-Reino J. Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-163-7.
• Brazilian biologic registry: BiobadaBrasilimplementation process and preliminary results.Titton DC, Silveira IG, Louzada-Junior P, Hayata AL, Carvalho HM, Ranza R, Rezende LS, Pinheiro GC, Santos JL, Miranda JR, Carvalho JF, Bertolo MB, Freire M, Scheinberg MA, Skare TL, Fernandes V, Bianchi W, Laurindo IM. Rev Bras Reumatol. 2011 Mar-Apr;51(2):152-60.
• BiobadaBrasil: Brazilian biologic registry. Titton DC. Rev Bras Reumatol. 2011 Mar-Apr;51(2):111-2.

Resumos apresentados no ACR

• 2019 – no 2113 Biological Therapy Is Associated with Faster Recovery and Lower Frequency of Switch Treatment in Patients with Chikungunya Fever Aline Razolin ¹, Claudia Marques ¹, Laurindo Rocha Jr², Hugo Lima ³, Lays Martins ¹, Anderson Almeida ¹, Priscila Oliveira ¹, Angela Duarte ¹, Moacyr Rego ¹, Maira Pitta ⁴ and Ieda Laurindo ⁵, ¹Universidade Federal de Pernambuco, Recife, Brazil, ²Instituto de Medicina Integral Professor Fernando Figueira – IMIP, Recife, Brazil, ³Instituto de Medicina Integral Professor Fernando Figueira – IMIP, Recife, Pernambuco, Brazil, ⁴Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil, ⁵BIOBADABRASIL comittee, São Paulo

• 2017- no278 Corticosteroid Use, Biologic Therapy Switching, Smoking and Renal Failure Are Associated with Serious Infections in Rheumatoid Arthritis Patients Treated with Biologics: Data from Two Latin-American Registries. Maria de la Vega, Gustavo Casado, Gustavo Citera, Ieda Maria Magalhães Laurindo, Georges Christopoulos, Miguel Angel Descalzo and Roberto Ranza.
• 2017-no541 Decreasing Trend of Serious Infections Incidence Rate Along Years in Rheumatoid Arthritis Patients Exposed to Biologics. Data from Two Latin America Registries. Roberto Ranza, Ieda Maria Magalhães Laurindo, Georges Christopoulos, Gimena Gomez, Enrique R Soriano, Miguel Angel Descalzo and Maria de la Veja
• 2016 – no1319 Chikungunya Fever in Patients on Biological and on Conventional Dmards  Therapy – Results from the Brazilian Register Biobadabrasil. Aline Ranzolin, Angela Duarte, Claudia Marques, Laurindo Rocha Jr, Samia Araujo de Souza Studart, José Caetano Macieira, Monica Valeria Siqueira S de Vechi, Lina Oliveira de Carvalho, Ines Guimarães da Silveira, Ieda Maria Magalhães Laurindo
• 2015-no2362 Incidence of adverse events in patients with rheumatoid arthritis and spondyloarthritis exposed to anti-TNF therapy. Data from the Brazilian registry for monitoring of biologic therapies in rheumatic diseases (BiobadaBrasil). Roberto Ranza, David C Titton, Valeria Vallim, Ines Silveira, Aline Ranzolin, Andre Hayata, Mirhelen M. Abreu, Paulo Louzada-Jr, Angela LBP Duarte, Claiton Brenol, Geraldo C Pinheiro, Glaucio R Castro, Hellen M Carvalho, Isaias Costa, Jose C Macieira, Jose R Miranda, Julio CM Bertacini, Luis SG Barbosa, Manoel B Bertolo, Marcelo M. Pinheiro, Maria F Sauma, Marilia B Silva, Marlene Freire, Roberto A Toledo and Vander Fernandes.

Resumos apresentados no EULAR:

• 2025 POS1173 Assessing The Impact Of The Smoking–Methotrexate Interaction On The Safety Of Anti-Tnf Therapy In Patients With Rheumatoid Arthritis And Spondyloarthritis,
  Bredemeier, A. D. M. Baier, C. V. Tavares, A. Duarte, M. Pinheiro, B. Stadler Kahlow, M. V. S. De Vechi, R. Ranza, J. R. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. da Silveira de Carvalho, S. Studart, G. da Rocha Castelar Pinheiro, L.Jr Rocha, H. de Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. M. Kakehasi, P.Jr Louzada, A. L. S. Hayata, C. Lupo, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Machado Xavier, I. M. Laurindo, J.E. Martinez
• 2025 ABS1061 Comparing The Safety of Adalimumab And Etanercept As The First Biologic In Rheumatoid Arthritis: A Simulated Randomized Controlled Trial Using Data From The Biobadabrasil Cohort. Bredemeier, E. Reginatto, M. Silvestri Pauwelz, A. Duarte, M. Pinheiro, B. Stadler Kahlow, M. V. S. De Vechi, R. Ranza, J. R. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. da Silveira de Carvalho, S. Studart, G. da Rocha Castelar Pinheiro, L.Jr Rocha, H. de Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. M. Kakehasi, P.Jr Louzada, A. L. S. Hayata, C. Lupo, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Machado Xavier, I. M. Laurindo, J. E. Martinez
• 2025 POS0478 The Effect Of Corticosteroids On The Risk Of Serious Adverse Events In Rheumatoid Arthritis: A Simulating A Randomized Controlled Trial Using Data From The Biobadabrasil Cohort, M. Bredemeier, A. D. M. Baier, C. V. Tavares, E. Reginatto, M. Silvestri Pauwelz, A. Duarte, M. Pinheiro, B. Stadler Kahlow, M. V. S. De Vechi, R. Ranza, J. R. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L.Jr Rocha, H. De Leon De Lima, I. Pereira, M. Ohira Gazzeta, A. M. Kakehasi, P.Jr Louzada, A. L. S. Hayata, C. Lupo, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Machado Xavier, I. M. Laurindo, J. E. Martinez
• 2024 POS0640 Antimalarials And The Risk Of Ocular Adverse Events In Rheumatoid Arthritis: Looking Beyond The Rare Occurrence Of Drug Induced Retinopathy, M. Bredemeier, S. Estefano Ramos, C. Solórzano, C. V. Tavares, A. M. Baier, A. Duarte, M. Pinheiro, B. S. Kahlow, M. V. S. De VeChi, R. Ranza, J. R. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L.Jr Rocha, H. De Leon De Lima, I. Pereira, M. Ohira Gazzeta, A. M. Kakehasi, P.Jr Louzada, A. L. S. Hayata, C. Lupo, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Machado Xavier, I. M. Laurindo, M. Antonio Araujo Da Rocha Loures
• 2024 POS0916 Drug Survival Of Biologic And Targeted Synthetic Disease-Modifying Antirheumatic Therapies In Patients With Inflammatory Arthritis: Data From Five Countries Of Latin America, D. Alpizar-Rodriguez, C. A. Isnardi, V. Rivera Terán, I. M. Laurindo, G. Pons-Estel, M. Haye Salinas, I. E. Exeni, R. N. Alvarado, G. Gomez, A. Brigante, M. Pinheiro, R. Ranza, G. Castro, V. Fernandes, C. Brenol, M. Antonio Araujo Da Rocha Loures, D. Vega-Morales, I. J. Colunga-Pedraza, S. Sicsik, M. A. Saavedra Salinas, J. C. Casasola, G. Avila, S. Cabrera-Villalba, P. Melgarejo, P. Pusineri, R. Aranda, P. Jara Gomez, M. Soto Estevez, C. Brunengo, D. Cordovilla, B. Acevedo, S. Consani-Fernández, S. Rostan, P. De Abreu Trigueros 

• 2024 POS0084 Safety Of Targeted Therapies In Immune Mediated Inflammatory Diseases: Combined Data From Five Countries Of Latin America, De Abreu Trigueros, D. Alpizar-Rodriguez, V. Rivera Terán, I. M. Laurindo, G. Pons-Estel, M. Haye Salinas, M. A. Alfaro, V. Saurit, E. Catay, G. Medina, B. Stadler Kahlow, J. R. Miranda, M. Bertolo, A. C. Medeiros-Ribeiro, H. M. Da Silveira De Carvalho, M. Antonio Araujo Da Rocha Loures, A. Castillo Ortiz, F. Irazoque-Palazuelos, O. E. Muñoz-Monroy, S. Carrilo, A. Peña-Ayala, S. Cabrera-Villalba, G. Avila, L. Roman, A. Pineda, C. Parodi, L. Martín, D. Cordovilla, M. Soto Estevez, C. Brunengo, B. Acevedo, G. Batershagui, C. Díaz, C. A. Isnardi On Behalf Of Biobadasar, Biobadaguay, Biobadamex And Biobadabrasil

• 2024 AB0508 The Effect Of Combinations Of Conventional Synthetic Dmards On The Safety And Treatment Retention Of Biologic Agents Or Jak Inhibitors In Rheumatoid Arthritis, Ramos, M. Bredemeier, C. Solórzano, C. V. Tavares, A. M. Baier, A. Duarte, M. Pinheiro, B. Stadler Kahlow, M. V. S. De Vechi, R. Ranza, J. R. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L.Jr Rocha, H. De Leon De Lima, I. Pereira, M. Ohira Gazzeta, A. M. Kakehasi, P.Jr Louzada, A. L. S. Hayata, C. Lupo, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Machado Xavier, I. M.Laurindo, M. Antonio Araujo Da Rocha Loures On Behalf Of Biobadabrasil

• 2023 OPO223 The effect of antimalarials on the risk and severity of bacterial, viral, fungal and systemicspecific infections in rheumatoid arthritis Bredemeier, M. Campos, F. Della, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha Jr, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada Jr, A. L. S. Hayata, F. Pina, C. Lupo, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Xavier, I. Laurindo, M. Antonio Araujo Da Rocha Loures. (este trabalho – apresentação oral –  foi selecionado para apresentação na plataforma medscape)

• 2023 AB0428 Safety and persistence of treatment with Golimumab versus Certolizumab in rheumatoid arthritis: Results from BiobadaBrasil cohort study. Bredemeier, S. Ramos, C. Solórzano, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha Jr, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P. Louzada Jr, A. L. S. Hayata, F. Pina, C. Lupo, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, A. Ranzolin, R. Xavier, I.Laurindo, M. Antonio Araujo Da Rocha Loures
• 2022 POS0242 The effect of antimalarials on the overall safety and persistence of treatment with biologic agents or jak inhibitors in rheumatoid arthritis. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P.Jr Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier on behalf of BiobadaBrasil – apresentado oralmente como parte do “poster tour”
• 2022 POS0650 The impact of old age on the persistence and safety of treatment with biologic agents or jak inhibitors in rheumatoid arthritis. Chakr, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. C. Medeiros-Ribeiro, R. Botelho, C. Brenol, H. M. Da Silveira De Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L.Jr Rocha, I. Pereira, H. De Leon de Lima, M. Ohira Gazzeta, A. Kakehasi, P.Jr Louzada, A. L. S. Hayata, F. Pina, C. Lupo, L. Balarini, I. Silveira, S. Schowalski, D. Titton, A. Ranzolin, I. Laurindo, R. Xavier
• 2022 AB1173 Incident cases of covid-19 and vaccination adherence in a multicentric cohort of inflammatory arthritis in Brazil. M M de Souza, A. C. Medeiros-Ribeiro, M. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, R. Botelho, C. Brenol, H. M. Da Silveira DE Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, H. De Leon de Lima, I. Pereira, M. Ohira Gazzeta, A. Kakehasi, P.Jr Louzada, A. L. S. Hayata, F. Pina, M. Alves Ferreira, L. Balarini, I. G. Silveira, S. Kowalski, D. Titton, R. Mendonça Da Silva Chakr, A. Ranzolin, I. Laurindo, R. Xavier.
• 2021 POSO676 Survival of the first course of biologic or jak inhibitor in rheumatoid arthritis: association with the choice of agent and concomitant conventional synthetic DMARDs. Bredemeier, A. Duarte, M. Pinheiro, B. Stadler, J. C. Macieira, R. Ranza, J. Miranda, V. Valim, G. Castro, M. Bertolo, M. D. F. Sauma, V. Fernandes, A. Medeiros², R. Botelho, C. Brenol, D. Negrão Gonçalo Dias, H. Carvalho, S. Studart, G. Da Rocha Castelar Pinheiro, L. Rocha, I. Pereira, M. Ohira Gazzeta, A. Maria Kakehasi, P.Jr Louzada, A. L. S. Hayata, F. Pina, C. Lupo, L. Balarini, I. Silveira, S. Kowalski, D. Titton, R. Chakr, A. Ranzolin, I. Laurindo, R. Xavier
• 2019 SAT0123 Risk for tuberculosis during treatment with biological therapy: is it time for reviewing screening protocol? – results from Brazilian registry of biological therapies in rheumatic diseases (BiobadaBrasil). Ana Medeiros, M Bredemeier, V Valim, M Pinheiro, C Macieira, A Duarte, B Stadler, R Ranza, M Bertolo, J Miranda, C Brenol, G Castro, V Fernandes, D Titton, F Sauma, I Pereira, R Botelho, H Carvalho, A Hayata, P Louzada, A Ranzolin, S Studart, G Castelar, A Kakehasi, W Bianchi, R Acayaba, I Silveira, H Resende, J Amaral, L Rocha, M Gazzeta, L Carvalho, S Schowalski, D Feldman, I Laurindo, J Provenza
• 2019 FR0142 Safety of the methotrexate-leflunomide combination in the Brazilian registry of biological therapies in rheumatic diseases (BiobadaBrasil) Markus Bredemeier, Ieda M. M. Laurindo, Roberto Ranza, Valéria Valim, Inês G. da Silveira, André L. S. Hayata, Aline Ranzolin, Paulo Louzada Jr., Daniel Feldman, David C. Titton, Sérgio C. Kowalski, and Ana C. Medeiros
• 2018 ABO6154 Disease activity state in patients with rheumatoid arthritis included in the BiobadaBrasil registry M. M. Laurindo* , M. Pinheiro, J. Macieira, A. Duarte, B. Kahlow, R. Ranza, J. Miranda, M. Bertolo, V. Valim, G.Castro, M. D. F. Lobato, D. Titton1, R. Teodoro, J. Moraes, C. Brenol, I. Costa, V. Fernandes, H. Carvalho, I.Pereira, W. Bianchi, A. Hayata, P. Louzada, A. Kakehasi, R. Toledo, G. Castelar, I. Silva, A. Ranzoline, G.Christopoulos.
• 2016 SAT0586 Herpes Zoster in the Brazilian register -BiobadaBrasil. Carvalho, I.M.M. Laurindo, R. Ranza, D. Titton, M. Bertolo, W. Bianchi, C. Brenol, G. Castelar, G. Castro, I. Costa, A. Duarte, V. Fernandes, M. Freire, P. Louzada, J. Macieira, J. MIranda, J. Moraes, I. Pereira, M. Sauma, B. Stadler, R. Toledo, V. Valim

• 2016 SAT0601 Incidence of serious infections in patients with rheumatoid arthritis and spondyloarthritis exposed to a-TNF therapy. results from BiobadaBrasil registry Ranza, I. Laurindo, D. Titton, M. Bertolo, W. Bianchi, C. Brenol, H. Carvalho, G. Castro, M. Cecconi, I. Costa, A. Duarte, V. Fernandes, M. Freire, P. Louzada-Jr, J. Maciera, J. Miranda, J. Moraes, I. Pereira, G. Pinheiro, M. Sauma, B. Stadler, R. Tol.

• 2016 THU0631 Incidence of serious adverse events in patients with rheumatoid arthritis exposed to biologic therapies. results from BiobadaBrasil registry Ranza, I. Laurindo, D. Titton, M. Bertolo, W. Bianchi, C. Brenol, M. Bustamante, H. Carvalho, G. Castro, I. Costa, A. Duarte, V. Fernandes, M. Freire, P. Louzada-Jr, J. Maciera, J. Miranda, J. Moraes, I. Pereira, G. Pinheiro, M. Sauma, B. Stadler, R Tol.

• 2016 FRI0195 Switching from anti-TNF to non anti-TNF therapy yield better survival in rheumatoid arthritis (RA): results from Brazilian register of biological agents in rheumatic diseases – BiobadaBrasil , Falcão, V. Valim, D. Titton, R. Ranza, H. Carvalho, W. Bianchi, B. Stadler, V. Fernandes, P. Louzada, M. Bertolo, A. Duarte, J. Macieira, J. Miranda, G. Castelar, M. Freire, R. Toledo, J. Moraes, I. Costa, I. Pereira, M. Sauma, G. Castro, C. Brenol

• 2015 SAT0362 Incidence of adverse events in patients with rheumatoid arthritis and spondyloarthritis exposed to anti-TNF therapy. data from the Brazilian registry for monitoring of biologic therapies in rheumatic diseases (BiobadaBrasil) ,R. Ranza, I. Laurindo, D. Titton, L. Barbosa, M. Bertolo, J. Bertaccini, C. Brenol, H. Carvalho, G. Castro, M. Cecconi, I. Costa, A. Duarte, V. Fernandes, M. Freire, P. Louzada. Jr, J. Macieira, J. Miranda, I. Pereira, G. Pinheiro, M. Pinheiro, M. Sauma
• 2013 AB0524 Biological agents survival comparisons among different rheumatic disease – Brasilian register of biological agents in rheumatic diseases – BiobadaBrasil ,B. Fafá, V. Valim, P. Peçanha, I. Laurindo, A. Ranzolin, A. Hayata, Â. Duarte, C. Brenol, H. Carvalho, G. C. Pinheiro, I. Silveira, I. A. Pereira, I. Costa, J. Macieira, J. R. Miranda, J. C. Moraes, L. S. G. Barbosa, M. Bértolo
• 2010 AB0958 Biologic register in a developing country: safety is different from European registries? the BiobadaBrasil first results. Titton, A. Hayata, H. Carvalho, I. Silveira, J. Miranda, L. Rezende, M. Bertolo, M. Scheinberg, P. Louzada Jr, R. Ranza, T. Skare, V. Fernandes, W. Bianchi, I. Laurindo

• 2010 AB0299 Biologic register: experience with implementation and first practical outcomes. Titton, A. Hayata, H. Carvalho, I. Silveira, J. Miranda, L. Rezende, R. Ranza, M. Bertolo, M. Scheinberg, P. Louzada Jr, T. Skare, V. Fernandes, W. Bianchi, I. Laurindo.

• 2010 THU0193 Survey reports may not reflect actual clinical practice: the case of methotrexate and folic acid , Pereira, D. Titton, A. Hayata, B. Cruz, C. Xavier, F. Rocha, G. Pinheiro, H. Carvalho, J. Miranda, L. Rezende, M. Bertolo, M. Scheinberg, P. Louzada Jr, R. Xavier, R. Ranza, T. Skare, V. Fernandes, W. Bianchi, I. Laurindo